Industries > Pharma > Top 25 Vaccines Market Forecast to 2029

Top 25 Vaccines Market Forecast to 2029

Prevnar/Prevnar 13, Gardasil/Gardasil 9, Fluzone/Vaxigrip, Pentacel, Infanrix, Pediarix, GSK Hepatitis Vaccine, Pneumovax 23, Varivax, Bexsero, Boostrix, Menactra, RotaTeq, Rotarix, Zostavax, Synflorix, FluLaval/Fluarix, ProQuad, M-M-R II, Adacel, Menveo, Repevax, Cervarix, FSME/IMMUN-TicoVac, Ixiaro, FluMist/Fluenz

PUBLISHED: 27 February 2020
PAGES: 190
PRODUCT CODE: PHA0440
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

covid-19

Visiongain expects market growth from $25.19bn in 2018 to $40.80bn in 2024, growing at a CAGR of 8.42%. The developing markets will continue to grow demand; this is mainly due to the great need for vaccines in low-income and middle-income countries.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 190-page report you will receive 53 tables and 59 figures– all unavailable elsewhere.

The 190-page report provides clear detailed insight into the top 25 vaccines market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Top 25 Vaccines Market revenue forecasts from 2019-2029:
• Adacel
• Bexsero
• Boostrix
• Cervarix
• FluLaval / Fluarix
• FluMist/Fluenz
• Fluzone/Vaxigrip
• FSME/IMMUN-TicoVac
• Gardasil/Gardasil 9
• Hepatitis Vaccines (GSK)
• Infanrix/Pediarix
• Ixiaro
• Menactra
• Menveo
• M-M-R II
• Pentacel
• Pneumovax 23
• Prevnar/Prevnar 13
• ProQuad
• Repevax
• Rotarix
• RotaTeq
• Synflorix
• Varivax
• Zostavax

Top 25 Vaccines Market Forecast to 2029

• Top 25 Vaccines Market revenue forecasts from 2019-2029 by Regional and National Market:
• US
• Canada
• Germany
• UK
• France
• Italy
• Spain
• Japan
• China
• India
• Brazil
• Mexico
• Russia
• South Africa
• RoW

The forecast for each regional market is further segmented by leading vaccines.

• Profiles of the selected leading companies:
• AstraZeneca
• Eli Lilly
• Emergent BioSolutions Inc.
• GlaxoSmithKline
• Johnson & Johnson
• Merck & Co.
• Pfizer
• Sanofi
• Serum Institute of India Private Limited
• Takeda

• Discussion on Research & Development:
• Prophylactic Vaccines: Paediatric Vaccines, Adult Vaccines, Elderly Vaccines, Travel Vaccines
• Therapeutic Vaccines

• Qualitative analysis of the generic drugs market:
SWOT Analysis of the vaccines market
STEP Analysis of the vaccines market
• Discussion on factors that drive and restrain the vaccines market

• Key Questions Answered by This Report:
• What is the current size of the overall global human vaccines market? How much will this market be worth from 2018 to 2029?
• What are the main drivers and restraints that will shape the overall vaccines market over the next ten years?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world vaccines? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2029?
• How will political and regulatory forces influence regional markets?
• How will market shares of the leading national markets change by 2029, and which geographical region will lead the market in 2029?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are the leading vaccines? What are their revenues and latest developments?
• What are some of the most prominent human vaccines currently in development?
• What are the main trends that will affect the world vaccines market between 2018 and 2029?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the social, technological, economic and political influences that will shape that industry over the next ten years?
• How will the Global Top 25 Vaccines Market evolve over the forecast period, 2018 to 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Top 25 Vaccines Market. You find data, trends and predictions.

Buy our report today Top 25 Vaccines Market Forecast : Prevnar/Prevnar 13; Gardasil/Gardasil 9; Fluzone/Vaxigrip; Pentacel; Infanrix, Pediarix; GSK Hepatitis Vaccine; Pneumovax 23; Varivax; Bexsero; Boostrix; Menactra; RotaTeq; Rotarix; Zostavax; Synflorix; FluLaval/Fluarix; ProQuad; M-M-R II; Adacel; Menveo; Repevax; Cervarix; FSME/IMMUN-TicoVac; Ixiaro; FluMist/Fluenz.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Top 25 Vaccines Market Forecast to 2029


Download sample pages

Complete the form below to download your free sample pages for Top 25 Vaccines Market Forecast to 2029


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories